| California: 'the Stem Cell State'. | |
| | |
MedLine Citation:
|
PMID: 21999272 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Interview with Jonathan Thomas We talked to Jonathan Thomas, newly elected Chairman of the California Institute for Regenerative Medicine (CIRM), a few weeks into a role he describes as "the opportunity of the lifetime" to find out what he sees as the key goals for the CIRM and why patient advocates are so critical to the future of the Institute. Jonathan Thomas was elected as Chairman of the California Institute for Regenerative Medicine (CIRM) in June 2011, succeeding the Founder and former Chairman, Bob Klein. Thomas has had a successful career in finance and law and is a Co-Founding Partner at Saybrook Capital, an investment banking and private equity firm. His commitment to patient advocacy and keen interest in biological sciences, developed as a Biology Major at Yale, led him to stand for Chairman. |
| | |
Authors:
|
Jonathan Thomas |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Regenerative medicine Volume: 6 ISSN: 1746-076X ISO Abbreviation: Regen Med Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-10-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278116 Medline TA: Regen Med Country: England |
Other Details:
|
Languages: eng Pagination: 113-5 Citation Subset: IM |
Affiliation:
|
California Institute for Regenerative Medicine, 210 King Street, San Francisco, CA 94107, USA. jthomas@cirm.ca.gov. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The world stem cell summit.
Next Document: Fighting for stem cell research.